Introduction The albumin-bilirubin (ALBI) grade is a novel indicator of the liver function.
Some studies showed that the ALBI grade was a prognostic and predictive biomarker for the …

OBJECTIVE: Our aim was to explore the prognostic role of baseline albumin-bilirubin levels
(ALBI) on the efficacy of immunotherapy in patients with advanced non-small cell lung …

Background Anti-programmed cell death receptor (PD)-1 antibody treatment results in better
prognosis than standard chemotherapy in patients with non-small cell lung cancer (NSCLC) …

Purpose PD-1 inhibitors have been routinely used to treat advanced non-small cell lung
cancer (NSCLC) and have significantly improved clinical outcomes. In this study, we aimed …

The liver is an essential organ for regulating innate and acquired immunity. We
hypothesized that the pre-treatment hepatic function affects the clinical outcome of immune …

Background Several serum markers have been associated with treatment response and
clinical outcome in non-small cell lung cancer (NSCLC) patients treated with immune …

OBJECTIVE: This study aimed to evaluate the prognostic significance of the LDH-to-albumin
ratio (LAR) in patients with non-small cell lung cancer (NSCLC) receiving nivolumab …

Objectives It has been reported nutritional status and systemic inflammation were associated
with the outcome of patients with malignancies. However, the prognostic value of …

Background Immune checkpoint inhibitors (ICIs) have appeared as a promising therapy
regimen for non-small cell lung cancer (NSCLC), but with an unsatisfying therapeutic …

Background. To assess the prognostic value of pretreatment serum biomarkers in stage IV
non‐small‐cell lung cancer (NSCLC) patients treated with PD‐1 (programmed cell death …